PROGASTRINE ET CANCERS S A R L has a total of 63 patent applications. It increased the IP activity by 11.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Australia and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOND BIOLOGICS LTD, ECS PROGASTRIN SA and SINGH MOLECULAR MEDICINE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Australia | 7 | |
#3 | Republic of Korea | 7 | |
#4 | Canada | 6 | |
#5 | Singapore | 6 | |
#6 | United States | 6 | |
#7 | Brazil | 5 | |
#8 | China | 5 | |
#9 | WIPO (World Intellectual Property Organization) | 5 | |
#10 | EAPO (Eurasian Patent Organization) | 3 | |
#11 | Serbia | 1 | |
#12 | Taiwan | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Prieur Alexandre | 53 |
#2 | Joubert Dominique | 5 |
#3 | Alexandre Prieur | 5 |
#4 | Hollande Frédéric | 4 |
#5 | Pannequin Julie | 3 |
#6 | Boudier Laure | 3 |
#7 | Houhou Leila | 1 |
#8 | Hollande Frederic | 1 |
#9 | Petremann Mathieu | 1 |
#10 | Houhou Leïla | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018379320A1 | Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer | |
WO2018178364A1 | Compositions and methods for treating lung cancer | |
US2021087265A1 | Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule | |
AU2017204685A1 | Compositions and methods for detecting and treating gastric cancer | |
EA037015B1 | Use and method for preventing or treating ovarian cancer using a composition comprising a progastrin-binding antibody | |
KR20210002363A | Compositions and Methods for Detecting and Treating Esophageal Cancer |